GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Float Percentage Of Total Shares Outstanding

Valeo Pharma (TSX:VPH) Float Percentage Of Total Shares Outstanding : 0.00% (As of Dec. 13, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Valeo Pharma's float shares is 0.00 Mil. Valeo Pharma's total shares outstanding is 98.66 Mil. Valeo Pharma's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Valeo Pharma's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Valeo Pharma's Institutional Ownership is 0.00%.


Valeo Pharma Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Valeo Pharma's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/98.66
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valeo Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
N/A
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
Executives
Luc Mainville Senior Officer
100079 Canada Inc. 10% Security Holder
Richard J. Mackay Director, Director or Senior Officer of 10% Security Holder
Steve Saviuk Director, Director or Senior Officer of 10% Security Holder, Senior Officer
Jeffrey Michael Skinner Senior Officer
Frederic Fasano Director
Guy Paul Allard Director or Senior Officer of 10% Security Holder, Senior Officer
Marc François Léger Senior Officer

Valeo Pharma Headlines

No Headlines